Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.25 USD | +0.48% | -2.51% | +23.17% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.17% | 762M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.43% | 22.1B | |
-9.33% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Earnings Flash (WVE) WAVE LIFE SCIENCES USA Reports Q4 Revenue $29.1M, vs. Street Est of $19.8M